REMINDER CPNI COVID-19 CU#151 ECHO Session *** Tonight at 7:30pm ***
Dear Colleague,
Please note, an additional 15 minutes has been added to the agenda to allow a short update on Smoking Cessation delivered by Colette Rogers Head of Health and Social Wellbeing Improvement (south) Regional Strategic Lead for Tobacco Control.
See amended agenda (attached).
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague,
Further concessionary prices have been granted for November 2020:
| Drug | Pack Size | Concessionary Price |
| Desmopressin 10micrograms/dose nasal spray | 60 dose | £22.81 |
| Docusate 100mg capsules | 30 | £3.20 |
| Olmesartan medoxomil 40mg tablets | 28 | £3.46 |
| Prochlorperazine 5mg tablets | 28 | £1.49 |
| Senna 7.5mg tablets | 60 | £2.76 |
| Sulfasalazine 500mg tablets | 112 | £6.88 |
Kind regards,
Gareth
SENT FOR AND BEHALF OF GARETH C. GILVARY | Governance & Support Pharmacist
*** Please REMEMBER to complete and submit your weekly Community Pharmacy Sit Report BEFORE 12 NOON TODAY ***
Thank You.
Sent by CPNI OFFICE
Dear Colleague,
Weekly Alert Summary
| Weekly Summary | 20.11.2020 |
| Northern Ireland Medicines Management Specials Supplement Nov 2020 | See CPNI Contractor Update 201118A |
| Northern Ireland Medicines Management Newsletter Nov 2020 | Naproxen EC to Plain Switch could save £0.6 million; FreeStyle Libre® 2 Sensor; Safety Lancets; Building the Community-Pharmacy Partnership Programme; NICE Guidance — NI Service Notifications; Managed Entry Decisions |
| REMINDER SUSPENSION OF PLANNED PRIADEL® TABLETS DISCONTINUATION 12th October 2020 | Healthcare professionals are asked to reassure patients that it is not necessary to switch from their Priadel® tablets to an alternative lithium carbonate preparation at this time, as there are no plans to discontinue Priadel® tablets. |
| Drug alerts available here: | BSO Communications (Drug Alerts) |
| Shortages Information available here: | BSO Shortages Information |
Pharmacy team(s) can keep updated with drug information, alerts and shortages information via CPNI’s contractor calendar here or via the BSO website here.
Please bring this to the attention of your pharmacy team(s).
Kind regards,
Kerry
Sent on behalf of Kerry Grimes | Governance & Support Pharmacist
Dear Colleague,
Please find attached agenda for the ECHO session that is scheduled to take place on 24th November 2020 from 7.30pm to 9.00pm. Topics covered will include ‘Repeat Prescription Management’ and ‘Response to Psychological Impact to COVID-19’.
Please use the meeting ID and passcode below to access the meeting:
Meeting ID: 532 210 9079
Passcode: 371722
Please also find attached ECHO Attendee/Moodle Guidance Notes and Project ECHO Enhanced Security Measures.
Please share this with your pharmacist(s).
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
*** FOR ACTION *** DISCONTINUE USE OF TARGET AND HSCB ANTIMICROBIAL PATIENT INFORMATION LEAFLETS
Please find attached for your attention, correspondence from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management and Dr. Margaret O’Brien, Assistant Director of Integrated Care, Head of General Medical Services (GMS).
Please do not hesitate to contact your local HSCB office, details included below, should you require any further information or clarification.
Contact Details for Local Integrated Care Offices:
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
